Skip to main content

Table 5 Sex-specific prevalence of individual metabolic abnormalities1 among study participants with NCEP diagnosed metabolic syndrome

From: Prevalence of the metabolic syndrome and its components in Northwest Russia: the Arkhangelsk study

Metabolic abnormality

Prevalence

 

Men (N = 210)

Women (N = 347)

Total (N = 557)

 

%

95 % CI

%

95 % CI

%

95 % CI

Central obesity

37.1

30.6-43.7

82.4

78.4-86.5

65.4

61.4-69.3

High TG

83.8

78.8-88.8

71.2

66.4-76.0

76.7

73.1-80.2

Low HDL-C

85.7

80.9-90.5

88.8

85.4-92.1

87.6

84.9-90.4

AH

93.8

90.5-97.1

89.1

85.8-92.4

90.8

88.4-93.3

Elevated SG

33.3

26.9-39.8

18.4

14.3-22.5

24.1

20.5-27.6

Elevated HBA1c

17.1

12.0-22.3

14.4

10.7-18.1

15.4

12.4-18.5

  1. 1 Central obesity: WC ≥88 cm (women) and ≥102 cm (men); High TG: triglycerides ≥1,7 mmol/l; Low HDL-C, high-density lipoprotein cholesterol <1,29 mmol/l (women) and <1,04 mmol/l (men); Arterial hypertension (AH): SBP ≥ 130 mmHg, or DBP ≥ 85 mmHg, or Rt for hypertension ; Elevated SG: serum glucose ≥6.1 mmol/l or self-reported DM, or Rt for hyperglycemia; Elevated HBA1c: glycated haemoglobin ≥6.1% or self-reported DM, or Rt for hyperglycemia
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us